Malathion (Ovide)
Cholinesterase Inhibitor class · 1 generic manufacturer · 1 ANDAs filed at FDA.
$515,631 in CY2024 Part D spend3K claims · 2K beneficiaries · 329 plans surveyed
Questions a plan sponsor actually asks.
What is Malathion used for?
Malathion is tracked in Medicare Part D. Specific indication information is not available in our current dataset.
Is there a generic for Malathion?
Yes. 1 ANDAs filed at FDA, 1 generic manufacturers currently shipping.
How much does my plan pay for Malathion?
Across 329 Part D plans, Malathion averages $3.19/unit (NADAC). Lowest available: $3.19/unit. Highest in distribution: $3.19/unit.
Is Malathion on the FDA shortage list?
No. Malathion is not currently on the FDA Drug Shortage Database.
6 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (1 approvals on file) · NADAC unit costs: CMS NADAC weekly file (1 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.